What are Antiretroviral drugs?

Antiretroviral drugs are pharmacologic agents that share a common mechanism (typically targeting HIV-1). 2 are currently marketed, with 3 more in clinical development.

What are the marketed Antiretroviral drugs?

Marketed Antiretroviral drugs include Part B: Multiple-dose ATM-AVI, Cohorts 1-4, highly active antiretroviral therapy (HAART).

Antiretroviral

2 marketed 3 in Phase 3

This page covers all Antiretroviral drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HIV-1, HIV enzymes and processes, HIV.

Targets

HIV-1 · HIV enzymes and processes · HIV

Marketed (2)

Part B: Multiple-dose ATM-AVI, Cohorts 1-4 · Pfizer · Infectious Disease
The mechanism of part-b-multiple-dose-atm-avi-cohorts-1-4 is not specified.
highly active antiretroviral therapy (HAART) · National Institute of Allergy and Infectious Diseases (NIAID) · Immunology
HAART combines multiple antiretroviral drugs to inhibit different stages of the HIV life cycle, thereby reducing viral replication and improving immune function.

Phase 3 pipeline (3)

stable HAART · A.O. Ospedale Papa Giovanni XXIII · Infectious Diseases
Stable HAART refers to a long-term antiretroviral therapy regimen that maintains viral suppression in HIV-1 infected patients.
Ongoing cART regimen · ViiV Healthcare · Infectious Diseases
cART regimens combine multiple antiretroviral drugs to suppress HIV replication by targeting different stages of the viral life cycle.
Colaren in HIV negative · University of Guadalajara · Infectious Diseases
Colaren is an investigational drug that targets the HIV virus.